title: New therapy for managing moderate to severe chronic obstructive pulmonary disease.
authors.forename: Andrew
authors.initials: A
authors.lastname: Chou
authors.forename: Anthony D
authors.initials: AD
authors.lastname: D'Urzo
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003521:Cyclopropanes / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D015337:Multicenter Studies as Topic; D058988:Phosphodiesterase 4 Inhibitors / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D000068299:Salmeterol Xinafoate; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D012720:Severity of Illness Index; D000069447:Tiotropium Bromide
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000631:Aminopyridines; D001549:Benzamides; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; D012602:Scopolamine Derivatives; C424423:Roflumilast; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000069447:Tiotropium Bromide
references.citation: N Engl J Med. 2007 Feb 22;356(8):775-89
references.pmid: 17314337
references.citation: Can Respir J. 2008 Jan-Feb;15 Suppl A:1A-8A
references.pmid: 18292855
references.citation: N Engl J Med. 2008 Oct 9;359(15):1543-54
references.pmid: 18836213